Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
SCTX
Scribe Therapeutics, Inc.
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$18.41
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Market cap
$348.44M
RECENT INSIDER TRADES
2026-07-29
· ORBIMED ADVISORS LLC
(Director)
· BUY
2026-07-29
· GORDON CARL L
(Director)
· BUY
2026-07-29
· AH Bio Fund II, L.P.
(10% Owner)
· BUY
2026-07-28
· Aghazadeh Behzad
(Director)
· BUY
RECENT NEWS
Cathie Wood’s ARK adds to Scribe Therapeutics stock position
Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Scribe Therapeutics, Inc. (SCTX) · Stock Price, Insider Trades, News · CatalystPit